Copenhagen - Delayed Quote DKK

Pharma Equity Group A/S (PEG.CO)

Compare
0.1590
+0.0020
+(1.27%)
At close: January 31 at 4:59:38 PM GMT+1
Currency in DKK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
28,879.0000
25,294.0000
11,277.0000
-56.0000
12,135.0000
Operating Income
-28,879.0000
-25,294.0000
-11,277.0000
56.0000
-12,135.0000
Net Non Operating Interest Income Expense
-6,690.0000
-1,548.0000
-22.0000
486.0000
-272.0000
Pretax Income
-35,568.0000
-26,841.0000
-11,299.0000
5,392.0000
-32,875.0000
Tax Provision
-2,212.0000
-2,233.0000
-1,855.0000
--
--
Net Income Common Stockholders
-33,357.0000
-24,609.0000
-9,444.0000
5,392.0000
-32,875.0000
Diluted NI Available to Com Stockholders
-31,720.0000
-24,609.0000
-9,444.0000
5,392.0000
-32,875.0000
Basic EPS
-0.03
-0.02
-0.01
0.10
-1.03
Diluted EPS
-0.03
-0.02
-0.01
0.10
-1.03
Basic Average Shares
1,093,281.7500
1,080,360.0000
953,972.0000
55,570.8840
31,805.3940
Diluted Average Shares
1,116,940.0000
1,088,551.0000
977,348.0000
58,255.8840
31,805.3940
Total Operating Income as Reported
-24,477.0000
-20,891.0000
-11,277.0000
-1,444.0000
-2,135.0000
Total Expenses
28,879.0000
25,294.0000
11,277.0000
-56.0000
12,135.0000
Net Income from Continuing & Discontinued Operation
-33,357.0000
-24,609.0000
-9,444.0000
5,392.0000
-32,875.0000
Normalized Income
-33,357.0000
-24,609.0000
-9,444.0000
543.0000
-19,031.0000
Interest Income
-1,872.0000
14.0000
--
1,151.0000
--
Interest Expense
4,818.0000
1,562.0000
22.0000
665.0000
272.0000
Net Interest Income
-6,690.0000
-1,548.0000
-22.0000
486.0000
-272.0000
EBIT
-30,750.0000
-25,279.0000
-11,277.0000
6,057.0000
-32,603.0000
EBITDA
-30,322.0000
-24,799.0000
-11,277.0000
6,057.0000
-32,603.0000
Reconciled Depreciation
428.0000
480.0000
--
--
--
Net Income from Continuing Operation Net Minority Interest
-33,357.0000
-24,609.0000
-9,444.0000
5,392.0000
-32,875.0000
Total Unusual Items Excluding Goodwill
--
--
5,801.0000
4,849.0000
-13,844.0000
Total Unusual Items
--
--
5,801.0000
4,849.0000
-13,844.0000
Normalized EBITDA
-30,322.0000
-24,799.0000
-11,277.0000
1,208.0000
-18,759.0000
Tax Rate for Calcs
0.0001
--
--
--
--
12/31/2020 - 5/16/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LYTIX.OL Lytix Biopharma AS
5.60
+1.08%
 
BINV.ST BioInvent International AB (publ)
28.60
+5.73%
 
FLUI.ST Fluicell AB (publ)
0.0576
+3.60%
 
ACE.ST Ascelia Pharma AB (publ)
2.9150
+1.92%
 
RENB Renovaro Inc.
0.7500
-1.99%
 
FLUO.ST FluoGuide A/S
50.10
+1.11%
 
RLYB Rallybio Corporation
0.8599
-1.89%
 
TYRA Tyra Biosciences, Inc.
14.46
-1.70%
 
HNSA.ST Hansa Biopharma AB (publ)
34.46
+3.73%
 
PBLA Panbela Therapeutics, Inc.
0.3500
-2.78%